|
|
.
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
See Header: Dysphagia
ICD-10 (CM) Code and Descriptor
|
R13.14 |
Dysphagia, pharyngoesophageal phase
|
R1314 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 39.24%
|
20.03%
|
11.81%
|
8.33%
|
5.58%
|
3.92%
|
2.92%
|
2.01%
|
1.42%
|
1.01%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R13.14*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
92526
|
ORAL FUNCTION THERAPY |
9,853
|
9,854
|
|
92611
|
MOTION FLUOROSCOPY/SWALLOW |
5,394
|
5,396
|
|
74230
|
X-RAY XM SWLNG FUNCJ C+ |
5,305
|
5,306
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
3,483
|
3,493
|
|
74220
|
X-RAY XM ESOPHAGUS 1CNTRST |
3,229
|
3,229
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
2,461
|
62,230
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
2,265
|
4,179
|
|
92610
|
EVALUATE SWALLOWING FUNCTION |
1,986
|
1,986
|
|
97110
|
THERAPEUTIC EXERCISES |
1,743
|
2,826
|
|
43239
|
EGD BIOPSY SINGLE/MULTIPLE |
1,706
|
1,706
|
|
97530
|
THERAPEUTIC ACTIVITIES |
1,681
|
2,814
|
|
92507
|
TX SP LANG VOICE COMM INDIV |
1,412
|
1,414
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
940
|
941
|
|
J7120
|
RINGERS LACTATE INFUSION |
863
|
1,062
|
|
74221
|
X-RAY XM ESOPHAGUS 2CNTRST |
830
|
830
|
|
43249
|
ESOPH EGD DILATION <30 MM |
828
|
828
|
|
31575
|
DIAGNOSTIC LARYNGOSCOPY |
814
|
815
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
805
|
9,614
|
|
J3010
|
FENTANYL CITRATE INJECTION |
764
|
1,050
|
|
C1726
|
CATH, BAL DIL, NON-VASCULAR |
739
|
871
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R13.14 related to the following DRG Codes:
391-392
|
